Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable "Omicron ghosts" and insights from CAR-T cell therapy pointing toward better clinical outcomes.
Transfus Apher Sci
; 61(4): 103490, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-2016142
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
COVID-19
/
Neoplasms
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
/
Variants
Limits:
Humans
Language:
English
Journal:
Transfus Apher Sci
Journal subject:
Hematology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS